Immune dysregulation drives the relapse of peritoneal dialysis-associated peritonitis: a single-center prospective study - Scorecard - MDSpire

Immune dysregulation drives the relapse of peritoneal dialysis-associated peritonitis: a single-center prospective study

  • By

  • Guang Yang

  • Xingbo Hong

  • Zhiwei Lai

  • Hua Zhang

  • Zuying Xiong

  • Zibo Xiong

  • July 3, 2026

  • 0 min

Share

Clinical Scorecard: Immune System Imbalance Contributes to Recurrence of Peritoneal Dialysis-Related Peritonitis: Findings from a Single-Center Prospective Investigation

At a Glance

CategoryDetail
ConditionPeritoneal Dialysis-Associated Peritonitis (PDAP)
Key MechanismsImmune dysregulation and gut bacterial translocation
Target PopulationPatients undergoing peritoneal dialysis with recurrent PDAP
Care SettingSingle-center prospective investigation

Key Highlights

  • Relapsing PDAP is linked to peritoneal immune dysregulation and gut bacterial translocation.
  • A biomarker panel (CCL28, CD40, uPA, NRTN) distinguishes relapse from cure.
  • 16S rDNA sequencing increases pathogen detection rates to 83.9%.

Guideline-Based Recommendations

Diagnosis

  • Use conventional bacterial culture and 16S rDNA sequencing for pathogen detection.

Management

  • Consider immune-microenvironment-targeted management strategies.

Monitoring & Follow-up

  • Monitor levels of identified biomarkers for relapse prediction.

Risks

  • Prolonged antibiotic use and catheter removal due to relapsing PDAP.

Patient & Prescribing Data

31 patients with PDAP, including 23 cured and 8 with relapsing PDAP.

Relapsing PDAP may require tailored therapeutic strategies based on immune profiling.

Clinical Best Practices

  • Integrate multi-omics profiling for better understanding of PDAP relapse.
  • Adhere to ISPD guidelines for diagnosis and treatment of PDAP.

Related Resources & Content

Original Source(s)

Immune dysregulation drives the relapse of peritoneal dialysis-associated peritonitis: a single-center prospective study

  • by Guang Yang, Xingbo Hong, Zhiwei Lai, Hua Zhang, Zuying Xiong, Zibo Xiong

  • July 3, 2026

Related Content

Correction: Microbiome-innate immune crosstalk in acute exacerbation of idiopathic pulmonary fibrosis: an amplification framework

Inflammation Tied to Organ Failure Risk

Review outlines mechanisms, prognosis, and supportive care strategies in surgical and trauma ICU populations

The role of the complement system in gastrointestinal-related diseases